Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00268307 · ClinicalTrials.gov registry record · Phase 1
Bone Marrow Stem Cell Infusion Following a Heart Attack
A Phase 1 study of Acute Myocardial Infarction, sponsored by Minneapolis Heart Institute Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT00268307 is a Phase 1 study of Acute Myocardial Infarction that has completed, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 41 participants, below the 1,880-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00268307, a Phase 1 study of Acute Myocardial Infarction, has completed, sponsored by Minneapolis Heart Institute Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine the safety of giving a patient's own bone marrow-derived stem cells delivered with a catheter (tube) into the coronary arteries (blood vessels of the heart). Stem cells are simple cells produced by the bone marrow that can develop into many types of cells. It is possible that these cells will decrease the size of damage caused to the heart from a heart attack and increase the pumping efficiency of the heart; which can be decreased due to a heart attack. The stem cells will be taken from bone marrow and then given back into the heart vessels.
Conditions Studied
Interventions
- DRUG Autologous, Unfractionated Bone Marrow Mononuclear Cells
Study Locations (1)
Minnesota
- Minneapolis Heart Institute Foundation - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2005-12 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00268307
The ClinicalTrials.gov registry entry for NCT00268307 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,880-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (98% lower). The listed sponsor is Minneapolis Heart Institute Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which Autologous, Unfractionated Bone Marrow Mononuclear Cells is the first listed.
NCT00268307 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00268307 about?
NCT00268307 is a clinical study titled "Bone Marrow Stem Cell Infusion Following a Heart Attack". The goal of this study is to determine the safety of giving a patient's own bone marrow-derived stem cells delivered with a catheter (tube) into the coronary arteries (blood vessels of the heart). Stem cells are simple cells produced by the bone marrow that can develop into many types of cells. It i...
What is the current status of trial NCT00268307?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2005-12. Estimated completion is 2010-09.
What conditions does trial NCT00268307 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction.
What interventions are being tested in trial NCT00268307?
The interventions under investigation include: Autologous, Unfractionated Bone Marrow Mononuclear Cells (DRUG).
Who is sponsoring clinical trial NCT00268307?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00268307 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
RECRUITING
-
Abbott Vascular Medical Device Registry
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.